- Home
- ETNB vs SPNS Comparison
ETNB vs SPNS Comparison
Compare ETNB & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- SPNS
- Stock Information
- Founded
- ETNB 2018
- SPNS 1982
- Country
- ETNB United States
- SPNS Israel
- Employees
- ETNB N/A
- SPNS N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- SPNS Computer Software: Prepackaged Software
- Sector
- ETNB Health Care
- SPNS Technology
- Exchange
- ETNB Nasdaq
- SPNS Nasdaq
- Market Cap
- ETNB 1.5B
- SPNS 1.6B
- IPO Year
- ETNB 2019
- SPNS 1992
- Fundamental
- Price
- ETNB $9.23
- SPNS $42.69
- Analyst Decision
- ETNB Strong Buy
- SPNS Hold
- Analyst Count
- ETNB 8
- SPNS 3
- Target Price
- ETNB $26.29
- SPNS $31.33
- AVG Volume (30 Days)
- ETNB 1.6M
- SPNS 1.6M
- Earning Date
- ETNB 08-07-2025
- SPNS 08-13-2025
- Dividend Yield
- ETNB N/A
- SPNS 1.41%
- EPS Growth
- ETNB N/A
- SPNS N/A
- EPS
- ETNB N/A
- SPNS 1.22
- Revenue
- ETNB N/A
- SPNS $549,037,000.00
- Revenue This Year
- ETNB N/A
- SPNS $8.25
- Revenue Next Year
- ETNB N/A
- SPNS $6.85
- P/E Ratio
- ETNB N/A
- SPNS $34.99
- Revenue Growth
- ETNB N/A
- SPNS 3.08
- 52 Week Low
- ETNB $4.16
- SPNS $23.69
- 52 Week High
- ETNB $11.84
- SPNS $42.76
- Technical
- Relative Strength Index (RSI)
- ETNB 45.00
- SPNS 85.88
- Support Level
- ETNB $8.95
- SPNS $26.14
- Resistance Level
- ETNB $9.50
- SPNS $31.87
- Average True Range (ATR)
- ETNB 0.54
- SPNS 0.71
- MACD
- ETNB -0.03
- SPNS 1.80
- Stochastic Oscillator
- ETNB 42.60
- SPNS 99.61
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.